bBooth, Inc. ($BBTH) This Disruptive CRM Company can

New Post Public Reply Private Reply Replies (0) Message Board
Emerging-Growth
305
bBooth, Inc. ($BBTH) This Disruptive CRM Company can Dominate its $37 Billion Industry

If You could go Back and Buy SalesForce.com at $3.00, would You?

MIAMI, FL / ACCESSWIRE / April 20, 2017 / Customer relationship management or “CRM” refers to the practice, strategy and ultimately the technology that both corporations, and individuals use to manage and analyze interactions with prospective customers, with the goal of not only converting them to, but also maintaining them as clients.

There are many companies providing CRM software, and while they all tend to do things a little bit different, they’re all designed to compile data across different channels, ranging from managing basic contact information, to tracking social media posts which is designed to give the sales person an ice breaker to a conversation with a prospect or client. Some of the players in the space such as Zendesk, Inc. (NYSE: ZEN) and Pegasystems, Inc. (NASDAQ: PEGA), offer free trials, with services running upwards of $200.00 per month per user. Starting at that rate, you’ll find HubSpot, Inc.’s (NYSE: HUBS) basic services while SalesForce.com, Inc.’s (NYSE: CRM) “Unlimited Edition” will take you up to $300.00 per month.

In the end, they are all great tracking tools. The help management keep track of their sales people, and their sales people keep track of their prospects and clients. For the most part however, they focus more on sales team management and reporting, like email and phone call activity, and when to follow up, than actual selling.

Enter bBooth, Inc. (OTCQB: BBTH). bBooth has reinvented what a CRM, Lead-Generation tool should be in today’s video-centric social environment. Their service is built around their proprietary “Video-First” bNotifi technology, which places interactive video front and center in all customer and prospect communications. This is the missing piece to the CRM puzzle and bBooth is capitalizing on it.

During its incubation, bBooth CEO, Rory J. Cutaia didn’t set out to create another CRM product. He set out to re-invent what a CRM product should be, and has been recently named CEO of the Month by CIO Review, while bBooth, Inc. was named among the 20 most promising CRM solution providers for 2017 alongside the major, multi-billion dollar names in the industry mentioned above. But bBooth has something that none of the others have; bNotify.

bNotify is a land grab, but for the real estate on the screens of computers and mobile devices. In the battle for engagement of customers, consumers, members, and followers, bNotify is a powerful weapon. It is the first of its kind, “push to screen” technology which allows its users to push content of any kind, including text, graphics, photos, videos, and bBooth’s own propriety walk out style videos of which you can see examples of here. Most importantly, bNotify is interactive. You can now embed ecommerce capability, forms and documents that need completion, and so much more, right inside the videos, eliminating the need to open an attachment, complete, save, re-attach and send.

Are you hosting an event in your area? Select the audience and push it to their screen. They can RSVP, and even choose their main course with one click in the video.

Are you announcing a new product? Or entire product line? Push it to all your customers’ screens! Weather on mobile or desktop, there is no longer a need for a browser. Choose your item, or sign up for your service right within the bNotify interactive video. The technology is truly amazing.

bBooth, Inc. (OTCQB: BBTH) is posturing to become a major disruptor in the CRM space. With its proprietary bNotify software, and its listing among the 20 most promising CRM solution providers for 2017, it’s hard to imagine the majors not competing for it soon. bBooth, Inc. is a fully reporting company trading on the OTCQB market, with a current market cap of less than $10 million. It’s going to be interesting to see how quickly the company can ramp up and take the industry by storm.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks. This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. Full details about which can be found in our full disclosure, which can be found here, http://www.emerginggrowth.com/disclosure-2284/. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

Contact: info@EmergingGrowth.com

SOURCE: Emerging Growth.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Michael Burry Steps Back: Scion Asset Management Shuttered

Updated Category News Views 409

Michael Burry Withdraws Scion Asset Management Registration Michael Burry, renowned for his insightful market predictions, has recently decided to de-register his hedge fund, Scion Asset Management, LLC. This decision marks a significant transition in Burry's investment journey. Understanding the De-Registration Process According to the Securities and Exchange...

Continue Reading
Delta Air Lines Takes Legal Action Against CrowdStrike Over Disruption

Updated Category News Views 540

Delta Air Lines Challenges CrowdStrike in Court Delta Air Lines (NYSE: DAL) has taken a bold step by filing a lawsuit against CrowdStrike (NASDAQ: CRWD), arising from significant operational disruptions caused by a software update. This action is taking place in a Georgia state court, specifically the Fulton County Superior Court. Mass Flight Disruptions and Their...

Continue Reading
Innovative LungFit PH Gains Approval for Use in Australia

Updated Category News Views 178

Introduction of LungFit PH in Australia Beyond Air, Inc. (NASDAQ: XAIR) has exciting news for the medical field as it recently received market authorization for its LungFit PH system from the Australian Therapeutic Goods Administration (TGA). This development positions LungFit PH as a Class IIb medical device, designed to provide a controlled application of nitric oxide...

Continue Reading
Integral Molecular Introduces Paratope-PLUS™ for Antibody Claims

Updated Category News Views 169

Integral Molecular Unveils Paratope-PLUS™ for Enhanced Antibody Patenting This innovative technology aligns with new USPTO guidelines for writing robust antibody patent claims and supports advanced antibody engineering for unique intellectual property. Integral Molecular has launched a revolutionary service named Paratope-PLUS™. This new technology aims to improve...

Continue Reading
Nauticus Robotics Growth in Q2: A Positive Outlook Ahead

Updated Category News Views 223

Nauticus Robotics Shows Strong Growth Trajectory in Q2 Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in subsea robotics and software, has demonstrated remarkable momentum in its financial results for the second quarter. The company continues to expand its market presence and innovate its service offerings, reflecting a strong commitment to long-term,...

Continue Reading